The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Regulatory News (COA)

Share Price Information for Coats (COA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 86.30
Bid: 86.40
Ask: 86.70
Change: 1.10 (1.29%)
Spread: 0.30 (0.347%)
Open: 87.10
High: 87.10
Low: 85.30
Prev. Close: 85.20
COA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

27 Mar 2020 07:00

RNS Number : 7885H
Coats Group PLC
27 March 2020
 

27 March 2020

Coats Group plc

Update on trading and impact of Covid-19

Coats Group plc ('Coats,' the 'Company' or the 'Group'), the world's leading industrial thread manufacturer, today provides an update on trading and the impact of Covid-19.

 

In the light of the recent escalation in the Covid-19 outbreak we are particularly focused on 3 priorities in the immediate future. These are 1) continuing to ensure the health and safety of our employees, 2) cash management, and 3) supporting our customers and maintaining the critical elements of our supply chain.

Current trading and outlook

Sales in the first two months of 2020, aside from the previously stated $8 million adverse impact on our China business as a result of Covid-19, were broadly in line with expectations. Since reporting our Full Year 2019 Results on 5 March we have seen the global situation escalate within and beyond the industries in which we operate. This has begun to impact our global demand in March, as brands and manufacturers started to cancel or defer orders, for example due to large scale store closures. In addition, as at 26 March, due to enforced government closures, 15 of our around 50 manufacturing sites are currently subject to temporary shutdown. Indications from those governments are that these sites will return to production in the coming weeks, however we cannot rule out further enforced government closures in these and other geographies.

As a result of this, our Q1 2020 organic revenues will be around 8% down on Q1 2019, with an accelerating organic decline in March, which is expected to be around 15% down year-on-year. Due to current uncertainty over the level of demand reduction across the Group, we are not able at this stage to make accurate forecasts over Full Year 2020 revenues.

Balance Sheet strength

We entered 2020 with a robust Balance Sheet and generating significant levels of cash, which place us in a strong position to manage through this period.

Our committed debt facilities total $575 million across our Banking and US Private Placement group, with a range of maturities from late 2022 through to 2027, and at the end of 2019 we had $290 million of headroom available.

At the end of February, this headroom was $230 million, which is reduced from December 2019 due to the payment of $37 million for the Pharr High Performance Yarns acquisition in February, and normal working capital outflows in Q1. Our debt covenants are two-fold: leverage of no more than 3x EBITDA (0.65x at December 2019) and interest cover of no less than 4x (12.9x at December 2019), which both exclude the impacts of IFRS 16.

Whilst the outlook remains uncertain, we have performed scenario testing, including a significant decline in sales in Q2 and Q3, with a gradual improvement in Q4, which equates to a 30% organic sales decline for the Full Year. In this scenario we still project to operate within our existing facility headroom and covenants.

Management actions

Despite the uncertain environment, we remain confident in our ability to navigate our way through these difficult times. We are taking all necessary actions internally to manage our cost base and cash resources prudently.

These extensive actions include, but are not limited to, significantly reducing our 2020 capital expenditure by c.$30 million from $45-55 million to $15-25 million, temporarily flexing our manufacturing footprint, and reviewing all non-essential discretionary spend. In addition, the Board and Group Executive Team will take a 20% reduction in their salary and fees in Q2. We are also exploring all available government support schemes being put in place around the world, in relation to Covid-19. On cash actions, we are focused on managing our working capital, including heightened credit risk.

Finally, the Board has decided to cancel the proposed 2019 final dividend which was due to be approved at our forthcoming AGM in May. The Board will keep the 2020 interim dividend under review.

Conclusion

Despite these uncertain times, the Board remains confident in the Group's ability to successfully manage through this difficult period and our actions are the prudent ones to take at this time. We enter this phase of our 250+ year history in robust shape and as a market leader with an unrivalled global footprint. Alongside our enhanced operational agility this leaves us well placed to benefit from an acceleration in demand when the virus situation is resolved.

 

Our next scheduled update to the market will be our January-April 2020 trading update on 20 May 2020, prior to our 2020 Annual General Meeting. We will update the market sooner, if required, as events evolve.

 

 

 

 

Enquiry details

Investors

Rob Mann

Coats Group plc

+44 (0)20 8210 5175

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

_________________________________________________________________________________________

 

 

This announcement contains inside information for the purposes of the Market Abuse Regulation.

 

 

About Coats Group plc

Coats is the world's leading industrial thread company. At home in some 50 countries, Coats has a workforce of 17,000 people across six continents. Revenues in 2019 were US$1.4bn. Coats' pioneering history and innovative culture ensure the company continues leading the way around the world. It provides complementary and value added products, services and software solutions to the apparel and footwear industries. It applies innovative techniques to develop high technology Performance Materials threads, yarns and fabrics in areas such as Transportation, Telecommunications and Energy, and Personal Protection. Headquartered in the UK, Coats is a FTSE 250 company, a constituent of the FTSE4Good Index Series and a participant in the UN Global Compact. To find out more about Coats visit www.coats.com.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKABNFBKDDNB
Date   Source Headline
7th May 20241:16 pmRNSHolding(s) in Company
5th Apr 202410:50 amRNSBlock listing Interim Review
25th Mar 20242:16 pmRNSDirector/PDMR Shareholding
25th Mar 20242:15 pmRNSDirector/PDMR Shareholding
13th Mar 20243:55 pmRNSAnnual Financial Report
8th Mar 202412:27 pmRNSDirector/PDMR Shareholding
8th Mar 202412:25 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNS2023 Full Year Results
29th Feb 202410:03 amRNSHolding(s) in Company
29th Feb 20249:59 amRNSHolding(s) in Company
14th Dec 20232:13 pmRNSDirector Declaration
7th Dec 20237:00 amRNSSwitch off of Pension Deficit Repair Payments
22nd Nov 20237:00 amRNSTrading Statement
21st Nov 20239:22 amRNSHolding(s) in Company
16th Nov 20232:02 pmRNSHolding(s) in Company
15th Nov 20239:00 amRNSChange of Senior Independent Director
1st Nov 20231:38 pmRNSHolding(s) in Company
9th Oct 202312:10 pmRNSBlock listing Interim Review
5th Oct 20237:00 amRNSDirectorate Change
27th Sep 202312:32 pmRNSDirector/PDMR Shareholding
25th Sep 20232:56 pmRNSHolding(s) in Company
14th Sep 202311:47 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSDeal Completion
4th Aug 202311:54 amRNSDirector/PDMR Shareholding
4th Aug 202311:48 amRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSDivestment of European Zips
6th Jun 20239:00 amRNSAppointment of Joint Corporate Broker
22nd May 202310:28 amRNSDirector Declaration
17th May 20234:23 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
12th Apr 202312:47 pmRNSBlock listing Interim Review
27th Mar 20234:15 pmRNSHolding(s) in Company
22nd Mar 202312:39 pmRNSHolding(s) in Company
20th Mar 20232:41 pmRNSDirector/PDMR Shareholding
20th Mar 20232:40 pmRNSDirector/PDMR Shareholding
17th Mar 20234:44 pmRNSDirectorate Change
14th Mar 202312:38 pmRNSHolding(s) in Company
14th Mar 202312:25 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSDirector/PDMR Shareholding
9th Mar 202311:23 amRNSAnnual Financial Report
3rd Mar 202312:20 pmRNSDirector/PDMR Shareholding
3rd Mar 202312:17 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNS2022 Full Year Results
23rd Feb 202310:31 amRNSHolding(s) in Company
20th Feb 20237:00 amRNS$250m US private placement
16th Feb 20239:19 amRNSHolding(s) in Company
9th Dec 20229:23 amRNSHolding(s) in Company
6th Dec 20227:00 amRNSUK pension scheme update
23rd Nov 20227:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.